Assal et al. reported that plasma adiponectin was significantly lower in obese patients with T2DM compared to obese nondiabetic and nonobese healthy subjects, but they did not include a group of nonobese patients with T2DM or patients with NAFLD in their study [19]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.